Inventage Lab, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2015-05-14
- Employees
- 69
- Market Cap
- -
- Website
- http://www.inventagelab.com
A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
Phase 1
Recruiting
- Conditions
- Opioid DependenceAlcohol Dependence
- Interventions
- First Posted Date
- 2022-11-17
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Inventage Lab., Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05620940
- Locations
- 🇦🇺
Nucleus Network, Herston, Queensland, Australia
A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.
Phase 1
Active, not recruiting
- Conditions
- Alzheimer Disease
- Interventions
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Inventage Lab., Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT05345509
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Australia
A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001
Phase 1
Completed
- Conditions
- Androgenetic Alopecia
- Interventions
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Inventage Lab., Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04945226
- Locations
- 🇦🇺
Nucleus Network, Brisbane, Australia
© Copyright 2025. All Rights Reserved by MedPath